REDX — Redx Pharma Share News
0.000.00%
- £35.01m
- £34.60m
- £4.20m
REG - Platinum Inv. Mgmnt Redx Pharma plc - Form 8.3 - Redx Pharma plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Jounce Therapeutics Redx Pharma plc - Recommended Business Combination
AnnouncementREG - Redx Pharma plc Jounce Therapeutics - Recommended Business Combination
AnnouncementREG - Redx Pharma plc - Notice of AGM
AnnouncementREG - Redx Pharma plc - Progress Update on RXC007 Clinical Programme
AnnouncementRCS - Redx Pharma plc - Redx to Present at Wnt & ß-Catenin Pathway Summit
AnnouncementREG - Redx Pharma plc - New Grant of Options
AnnouncementREG - Redx Pharma plc - Final Results for the Year Ended 30 September 2022
AnnouncementREG - Redx Pharma plc - Clinical Trial Agreement with MSD
AnnouncementREG - Redx Pharma plc - Notice of Preliminary Results
AnnouncementRCS - Redx Pharma plc - Redx to Present Poster at IBD Nordic Conference
AnnouncementREG - Redx Pharma plc - RXC004 Phase 2 Combination Arms to Open Enrolment
AnnouncementRCS - Redx Pharma plc - Redx to Present at Jefferies London
AnnouncementRCS - Redx Pharma plc - Redx Presenting at AFDD meeting
AnnouncementRCS - Redx Pharma plc - Redx to Present RXC004 Phase 1 Combination Data
AnnouncementRCS - Redx Pharma plc - Redx to Present Poster at ASN Kidney Week
Announcement